23 Feb uniQure
Richard Porter, Ph.D., Chief Business Officer
Oct. 11 | 2:15pm | UBC Ballroom
uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. We have developed a modular platform to rapidly bring new disease modifying therapies to patients with severe diseases.